Company
Avidity Biosciences, Inc.
Avidity Biosciences, Inc. has 1 drug tracked on RxWires: 1 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| AOC 1044 | Phase 3 | Muscular Dystrophies |
Latest
No recent events.
Follow Avidity Biosciences, Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.